Immunity & the Human Immune System
Complete UPSC notes — Lymphoid Organs, Immune Cells, Antibodies, Innate vs Acquired Immunity, Active vs Passive Immunity, Vaccination — with all 7 diagrams, PYQs, MCQs and Current Affairs.
2. Immune cells — WBCs: lymphocytes (B & T cells), neutrophils, macrophages, natural killers, monocytes
3. Soluble molecules — Antibodies (immunoglobulins), cytokines, interferons, complement proteins
| Feature | Innate Immunity | Acquired (Adaptive) Immunity |
|---|---|---|
| Present from | Birth (non-specific) | Developed after exposure to antigen |
| Specificity | Non-specific — acts on all pathogens | Pathogen-specific — tailored response |
| Memory | No immunological memory | Yes — memory B and T cells formed |
| Speed | Immediate (within minutes–hours) | Slower (days) first time; fast on re-exposure |
| Key cells | Neutrophils, Macrophages, NK cells | B lymphocytes, T lymphocytes |
| Key molecules | Interferons, complement proteins | Antibodies (immunoglobulins) |
| Examples | Skin barrier, stomach acid, phagocytosis, fever | Antibody production, CTL killing, vaccination |
The Lymphoid System. Left: Full body showing all lymphoid organs — Bone Marrow (in long bones — ALL blood cells including B/T cell precursors originate here), Thymus (above heart — T cell maturation), Spleen (left upper abdomen — filters blood, destroys old RBCs, houses lymphocytes), Lymph Nodes (distributed along lymph vessels — trap antigens from tissue fluid), Lymph Vessels (carry lymph fluid). Right: Close-up of a lymph node (bean-shaped, internal compartments) and the spleen (large, dark-red organ). Primary organs = Bone marrow + Thymus. All others = Secondary lymphoid organs.
→ Bone marrow (all blood cells formed here; B lymphocytes mature here)
→ Thymus (T lymphocytes mature here)
Secondary lymphoid organs: Where mature lymphocytes interact with antigens and mount an immune response.
→ Spleen, Lymph nodes, Tonsils, Peyer's patches (intestine), MALT
| Organ | Type | Location | Key Functions |
|---|---|---|---|
| Bone Marrow | Primary | Hollow cavities of long bones | Produces ALL blood cells (haematopoiesis). B lymphocytes mature here. T cell precursors produced here, then migrate to thymus. |
| Thymus | Primary | Above the heart (mediastinum) | T lymphocytes mature here. Produces thymosin hormone (promotes T cell maturation). Largest in infancy; shrinks with age (involutes after puberty). Very important for UPSC |
| Spleen | Secondary | Left upper abdomen | Bean-shaped. Filters blood; destroys old/damaged RBCs; houses lymphocytes and phagocytes; interacts with blood-borne antigens. Called "graveyard of RBCs." |
| Lymph Nodes | Secondary | Along lymph vessels (neck, armpit, groin) | Small, bean-shaped structures. Trap antigens from tissue fluid and lymph. Activate lymphocytes. Swell during infection (lymphadenopathy). |
| Tonsils | Secondary | Back of throat | First line of defence against inhaled/ingested pathogens. Part of MALT. |
| Peyer's Patches | Secondary | Wall of small intestine (ileum) | Monitor intestinal bacteria; protect against gut pathogens. Part of MALT. |
| MALT (Mucosa-Associated Lymphoid Tissue) | Secondary | Lining of digestive, respiratory, urogenital tracts | ~50% of all lymphoid tissue in the human body. Guards mucosal surfaces — major entry points for pathogens. Produces secretory IgA. |
Thymus = T cells mature here
Simple: B goes to Bone, T goes to Thymus
All Blood Cells Arise from ONE Stem Cell. The Haemocytoblast (pluripotent stem cell) in bone marrow gives rise to every type of blood cell. Left branch: Lymphoblasts → B lymphocytes (→ Plasma cells that make antibodies) and T lymphocytes. Middle: Monoblast → Monocyte → Macrophage. Myeloblast → Eosinophil, Basophil, Neutrophil (major innate immune cells). Right: Megakaryoblast → Thrombocytes (platelets); Proerythroblast → Erythrocytes (RBCs). Key UPSC point: All WBCs = immune cells; all originate from bone marrow. The pink area at the bottom shows the lymphocyte family (white blood cells of adaptive immunity).
T-Cell Development in the Thymus. T cell precursors from Bone Marrow migrate to the Thymus. Inside the thymus lobule (cortex), they pass through 4 double-negative (DN) stages: DN1→DN2→DN3→DN4. At the DN2 stage, CD25 receptors appear. By DN4, cells become double-positive (DP), expressing both CD4 and CD8 markers. In the medulla, cells undergo selection: CD4+ cells become Helper T cells (TH), CD8+ cells become Cytotoxic T cells (TC). This is thymic selection — ensures T cells respond to foreign antigens without attacking the body's own cells.
Surface marker: T-Cell Receptor (TCR)
Function: Cell-Mediated Immunity (CMI)
Helper T cells (TH / CD4+):
→ Express CD4 on surface
→ Central coordinator of adaptive immunity
→ Activate macrophages (phagocytosis), cytotoxic T cells (killing pathogens), and B cells (antibody production)
→ Think of TH as the "General" of the immune army
→ Express CD8 on surface
→ Directly kill intracellular pathogens (viruses inside cells) and cancer cells
→ Release perforin and granzymes to puncture and destroy infected cells
Suppressor T cells (TS):
→ Suppress both humoral and cell-mediated immune responses
→ Prevent autoimmune reactions (attacking own cells)
→ Also called Regulatory T cells (Tregs)
B Lymphocyte with B Cell Receptor (BCR). The B cell surface is studded with BCR (B Cell Receptors) — actually membrane-bound antibodies (IgM/IgD monomers). When an antigen binds to the BCR (top right — orange ball = antigen), it triggers B cell activation. Each B cell makes ONE unique BCR that recognises ONE specific antigen. After activation by TH cells: B cell divides into → Plasma cells (antibody factories) + Memory B cells (long-lived; provide future immunity). The colourful receptors on the left represent different surface molecules (CD markers, co-receptors) that help with signalling.
Surface markers: B Cell Receptor (BCR = membrane-bound antibody); CD19, CD20
First antibodies: IgM and IgD on surface as BCRs (not yet secreted)
Each B cell makes ONE unique antibody with ONE antigen-binding site
→ Plasma cells — antibody-secreting factories (live for days–weeks; produce millions of antibodies)
→ Memory B cells — long-lived (years to lifetime); basis of immunological memory
B cell response = Humoral Immune Response (antibodies in blood/lymph)
Also act as APCs (Antigen-Presenting Cells) to TH cells
Monocyte → Macrophage Differentiation. Circulatory Monocytes (small, with kidney-shaped nucleus) circulate in blood. When they migrate into tissues and are stimulated by cytokines, chemokines, TLR ligands, oxidative stress, etc., they differentiate into Macrophages (large, irregular shape, more granules). Macrophage classical functions: (1) Cytotoxicity & Fibrosis — kill pathogens, tumour cells, trigger tissue repair. (2) Phagocytosis, Chemokine & Cytokine production, Tissue surveillance — engulf and destroy pathogens, release chemical signals, continuously patrol tissues. (3) Antigen Presentation & T-Cell Activation — process antigens and present them to TH cells (key bridge between innate and adaptive immunity).
Type: Innate immune system cells (but bridge to adaptive immunity)
Functions:
1. Phagocytosis — engulf and destroy pathogens using lysosomes
2. Release cytotoxic proteins — kill tumour cells, intracellular bacteria, virus-infected cells
3. Antigen Presenting Cell (APC) — present antigens to TH cells via MHC complex
4. Activated by TH cells in a feedback loop
→ 50–70% of circulating WBCs
→ First cells to arrive at infection site (innate immune response)
→ Short-lived; die after killing pathogens
→ Also phagocytic
Natural Killer (NK) cells:
→ Lymphocytes of the innate immune system (not B or T cells)
→ Kill virus-infected cells and cancer cells WITHOUT needing antigen presentation
→ Kill cells that have lost MHC class I molecules (which cancer cells often do)
The Complete Adaptive Immune Response — From Microbe to Immunity. This is the most important diagram in immunology for UPSC. Step-by-step: ① Macrophage engulfs microbe (antigen from microbe = nonself molecule). ② Microbe is processed internally; fragments combined with self protein (MHC complex). ③ Self-nonself complex presented on macrophage surface = Antigen-Presenting Cell (APC). ④ T cell receptor (TCR) on Helper T cell recognises the complex. Interleukin-1 secreted by APC stimulates the Helper T cell. ⑤ Helper T cell is activated and secretes Interleukin-2. ⑥ Interleukin-2 activates B cells → Humoral Immunity (plasma cells secrete antibodies). ⑦ Interleukin-2 activates Cytotoxic T cells → Cell-mediated Immunity (attack infected cells directly). This diagram shows why Helper T cells (CD4+) are the "central coordinator" of ALL adaptive immunity.
- (a) They protect the body from environmental allergens
- (b) They alleviate the body's pain and inflammation
- (c) They act as immunosuppressants in the body
- (d) They protect the body from the diseases caused by pathogens ✓ Correct
Structure of an Immunoglobulin (Antibody) — Y-Shaped. Every antibody has this same basic architecture: Two identical Heavy (H) chains (purple — longer polypeptides) + Two identical Light (L) chains (yellow — shorter). All four chains are linked by Disulfide bonds (S-S). Each chain has two regions: Variable domain (VH and VL — shown at top — the unique antigen-binding region, different for every antibody) + Constant domain (CH1, CH2, CH3, CL — same within each class; determines the class of Ig). The two antigen-binding sites are at the top of each arm (circled, dashed). The hinge region (middle) allows flexibility. The Fc/effector region (bottom) determines which cells the antibody can bind to (macrophages, complement). Carbohydrate groups are attached to CH2. Each basic antibody is bivalent — can bind two identical antigens.
Variable domains (VH + VL) = antigen-binding sites (unique for each antibody).
Constant domains = determine the class (IgG, IgM, IgA, IgE, IgD).
The simplest antibody (monomer) is bivalent — 2 antigen-binding sites.
| Class | Structure | Key Functions | UPSC Points |
|---|---|---|---|
| IgG | Monomer (bivalent) | • Dominant in secondary immune response • Most abundant Ig in blood (~75%) • Activates macrophages and neutrophils • Fixes complement | ONLY Ig that crosses the placenta → protects newborn. Also found in breast milk. Major therapeutic antibody. |
| IgM | Pentamer (10 antigen-binding sites!) | • Dominates primary immune response • Most effective complement-fixing Ig • Potent agglutinin (clumps antigens) | First antibody produced. Monomer of IgM used as BCR (along with IgD). Largest Ig. ABO blood group antibodies are IgM. |
| IgA | Monomer (serum) or Dimer (secretory) | • Secretory IgA in mucosal secretions (saliva, tears, breast milk, gut lining) • Prevents antigen entry into blood | Most abundant Ig in mother's milk (colostrum). Primary defence at mucosal surfaces. ~15% of serum Ig. |
| IgE | Monomer | • Causes allergic reactions (binds to mast cells → histamine release) • Protection against parasites (helminths) | Lowest concentration in serum. Important in asthma, hay fever, food allergies. High IgE = allergic disease or parasite infection. CA Relevant |
| IgD | Monomer | • Present in very small amounts in serum • Function against pathogens unknown • Part of BCR | IgD may play role in antigen-triggered lymphocyte differentiation. Mostly serves as BCR on mature naive B cells (along with IgM). |
Or remember by order of abundance in serum: G > A > M > D > E
IgG = most abundant (75%); IgE = least abundant but most dramatic (allergies)
- (a) IgA
- (b) IgM
- (c) IgG ✓ Correct
- (d) IgE
Present from birth — no prior exposure needed
4 types of barriers:
1. Physical barriers:
→ Skin — primary barrier; mechanical block
→ Mucus lining gut, respiratory, urogenital tracts — traps microbes
→ Cilia in respiratory tract — sweeps microbes out
2. Physiological barriers:
→ Saliva (lysozyme enzyme kills bacteria)
→ Tears (lysozyme)
→ Stomach acid (HCl, pH 2 — kills most pathogens)
→ Human milk — contains antimicrobial factors
→ Fever — high temperature inhibits pathogen growth
→ Neutrophils (PMNL) — first to arrive; phagocytose pathogens
→ Macrophages — phagocytosis + APC
→ Monocytes — precursors to macrophages
→ Natural Killer (NK) cells — kill virus-infected and cancer cells without antigen presentation
4. Cytokine barriers:
→ Interferons — proteins secreted by virus-infected cells that PROTECT surrounding uninfected cells from viral infection
→ Complement system — cascade of proteins that punch holes in bacterial membranes and tag pathogens for destruction
Has memory — stronger response on re-exposure
Primary response: First exposure to antigen → slow, low-intensity response (days). Body is "learning." Produces memory cells.
Secondary response: Re-exposure to same antigen → rapid, high-intensity response (hours). Memory B and T cells recognise antigen immediately → massive antibody production. This is why vaccines work!
Humoral Immune Response (HIR):
→ B cells + plasma cells + antibodies in blood/lymph
→ Protects against extracellular pathogens
→ T lymphocytes (especially CD8+ cytotoxic T cells)
→ Kills intracellular pathogens (viruses inside cells)
→ Kills cancer cells
→ TH cells activate macrophages and cytotoxic T cells
→ Responsible for graft rejection (organ transplant rejection)
Key process:
Macrophage (APC) presents antigen via MHC → TH cell activated → Interleukin-2 released → Activates B cells (humoral) AND Cytotoxic T cells (CMI)
| Feature | Active Immunity | Passive Immunity |
|---|---|---|
| Definition | Antibodies produced by body itself in response to antigen exposure | Readymade antibodies transferred from outside (another individual/source) |
| How induced | Natural infection OR vaccination (intentional injection of antigen) | Mother to foetus (placenta, IgG), Mother to newborn (colostrum, IgA), Anti-serum injection |
| Memory | Yes — memory B and T cells formed → long-lasting | No — no memory cells formed → short-term |
| Onset | Slow (days to weeks) to develop fully | Immediate protection |
| Duration | Long-lasting (months to lifetime) | Short-lived (weeks to months) |
| Examples | Recovery from infection, COVID vaccine, flu vaccine, BCG vaccine | Maternal IgG via placenta, IgA via colostrum, Anti-rabies serum, Anti-snake venom serum (ASV) |
| UPSC note | Basis of vaccination programmes | Anti-snake venom = passive immunity; colostrum = passive immunity for newborn CA |
| Type of Vaccine | Description | Examples |
|---|---|---|
| Live-attenuated | Weakened (attenuated) live pathogen. Closest to natural infection — strong immune response. Cannot be given to immunocompromised. | BCG (TB), MMR (measles-mumps-rubella), Oral Polio Vaccine (OPV), Yellow fever, Varicella |
| Inactivated/Killed | Killed pathogen. Safer but weaker response; needs boosters. | Covaxin (India's COVID vaccine), IPV (Inactivated Polio), Hepatitis A, Flu vaccine (some) |
| Subunit/Protein | Only specific proteins (antigens) of the pathogen — not the whole pathogen. Very safe. | Hepatitis B vaccine, HPV vaccine (Gardasil/Cervarix), Pertussis component in DPT |
| Toxoid | Inactivated bacterial toxins. Train body to neutralise the toxin, not the bacteria itself. | Tetanus toxoid, Diphtheria toxoid (in DPT vaccine) |
| mRNA vaccines | mRNA encoding the antigen — body's cells produce antigen temporarily → immune response. Novel platform. Nobel Prize 2023 | Pfizer-BioNTech (Comirnaty), Moderna (Spikevax) — COVID-19 vaccines. India developing mRNA vaccine (HGCo19). |
| Viral vector | Another harmless virus (vector) carries antigen gene into body's cells. | Covishield (AstraZeneca/Serum Institute — Oxford), Sputnik V (Russia) — COVID vaccines |
Key vaccines under UIP: BCG (TB), OPV (polio), Hepatitis B, DPT (diphtheria, pertussis, tetanus), Hib (Haemophilus influenzae), Measles-Rubella (MR), Japanese Encephalitis, Rotavirus, Pneumococcal Conjugate Vaccine (PCV), IPV, Tetanus-diphtheria (Td) for pregnant women.
Mission Indradhanush — 2015 onwards; targets unimmunised/partially immunised children, especially in hard-to-reach areas.
India's COVID-19 vaccination: World's largest vaccination drive. Vaccines used: Covishield, Covaxin, Sputnik V, Corbevax, ZyCov-D (DNA vaccine — world's first approved DNA vaccine), iNCOVACC (intranasal vaccine — world's first approved intranasal COVID vaccine). High Yield CA
CERVAVAC — India's first indigenously developed HPV vaccine (by Serum Institute), approved 2022. Prevents cervical cancer. CA
- (a) The ability of the immune system to remember the first vaccine injected
- (b) The long-term ability of the immune system to recognise and mount a rapid response to a pathogen it has encountered before ✓ Correct
- (c) The ability of lymphocytes to retain the genetic code of antibodies
- (d) The capacity of vaccines to cause long-lasting side effects
Nobel 2018 (Physiology/Medicine): James P. Allison & Tasuku Honjo — cancer immunotherapy via immune checkpoint inhibition. Allison: CTLA-4 antibody (blocks immune brake); Honjo: PD-1 antibody (removes another brake). Unleashing the immune system to fight cancer.
Nobel 2011: Bruce Beutler & Jules Hoffmann — innate immunity mechanisms (Toll-like receptors, TLRs). Ralph Steinman — dendritic cells (APCs).
Nobel 1984: César Milstein & Georges Köhler — monoclonal antibody production via hybridoma technology.
ZyCov-D — World's first DNA vaccine: India approved Zydus Cadila's ZyCov-D for COVID-19 — world's first approved DNA vaccine. Needle-free administration via PharmaJet device.
iNCOVACC — World's first intranasal COVID vaccine: Developed by Bharat Biotech + Washington University. Nasal spray → mucosal immunity (secretory IgA). India first to approve.
CERVAVAC — India's HPV vaccine: Serum Institute. For cervical cancer prevention. India's government providing free HPV vaccination for girls 9–14 years (Union Budget 2023).
Long COVID & immune dysregulation: Research shows persistent immune activation, autoantibodies, and T cell exhaustion in Long COVID patients — major area of immunological research 2023–2025.
| Topic | Key Fact | UPSC Relevance |
|---|---|---|
| Autoimmune diseases | Immune system attacks own cells. Examples: Rheumatoid arthritis (joints), Type 1 Diabetes (pancreatic β-cells), SLE (Lupus), Multiple Sclerosis (nerves), Psoriasis (skin). Failure of Suppressor T cells (Tregs). | Asked in science questions; related to organ transplantation rejection (CMI). |
| Allergies | Exaggerated immune response to harmless antigens (allergens). IgE binds to mast cells → histamine release → inflammation, hay fever, asthma, anaphylaxis. Treatment: antihistamines, immunotherapy. | IgE role in allergies is high-yield. Anaphylaxis = life-threatening allergic reaction. |
| HIV/AIDS & Immunity | HIV attacks CD4+ Helper T cells → immune collapse. CD4 count <200/μL = AIDS. Opportunistic infections then kill the patient. AIDS = Acquired Immunodeficiency Syndrome — immune system destroyed. | Classic UPSC question: HIV attacks CD4+ T cells. India has 3rd largest HIV burden globally. |
| CAR-T cell therapy | Patient's T cells engineered to have Chimeric Antigen Receptors (CARs) that recognise cancer cells → infused back into patient → cancer killer cells. First gene-edited therapy. India approved 2024. | Cutting-edge immunotherapy; likely UPSC CA question. |
| Organ transplantation | Cell-mediated immunity causes graft rejection. Host's cytotoxic T cells attack transplanted organ. Immunosuppressants (cyclosporine, tacrolimus) needed to prevent rejection. MHC matching reduces rejection risk. | Transplantation biology — CMI's role in rejection. |
- (a) Bone marrow
- (b) Thymus
- (c) Spleen
- (d) Lymph nodes
- (a) B lymphocytes
- (b) Cytotoxic T cells (CD8+)
- (c) Helper T cells (CD4+)
- (d) Neutrophils
- (a) Virus-infected cells; they protect neighbouring uninfected cells from new viral infections
- (b) B cells; they neutralise bacteria in the bloodstream
- (c) Plasma cells; they are a type of antibody against viral antigens
- (d) Macrophages; they destroy intracellular bacteria
- (a) Active immunity developed by the child's own immune system
- (b) IgM antibodies transferred through the placenta
- (c) IgA antibodies transferred through the placenta
- (d) IgG antibodies transferred through the placenta — passive immunity
- (a) 10%; only in the intestinal lining
- (b) 25%; in the spleen and thymus
- (c) 50%; lining the digestive, urogenital, and respiratory tracts
- (d) 75%; distributed throughout all major organs
- (a) IgG
- (b) IgM
- (c) IgA
- (d) IgE
| Topic | Key Facts for UPSC |
|---|---|
| Definition | Ability to defend against pathogens. Immune system = lymphoid organs + immune cells (WBCs) + soluble molecules (antibodies, cytokines). |
| Primary lymphoid organs | Bone marrow (all blood cells + B cells mature here) + Thymus (T cells mature here). "B goes to Bone, T goes to Thymus." |
| Secondary lymphoid organs | Spleen (filters blood), Lymph nodes (trap antigens from lymph/tissue), Tonsils, Peyer's patches, MALT (50% of lymphoid tissue; mucosal surfaces). |
| T cells | Mature in thymus. TH (CD4+) = Helper T — activates macrophages, cytotoxic T cells, B cells = central coordinator. TC (CD8+) = Cytotoxic — kills virus-infected cells and cancer cells. TS = Suppressor/Regulatory Tregs. |
| B cells | Mature in bone marrow. → Plasma cells (produce antibodies) + Memory B cells. Humoral immune response. BCR = membrane-bound antibody (IgM/IgD). |
| Macrophages | Myeloid origin (Monocyte → Macrophage). Phagocytosis + APC (presents antigens to TH via MHC). Bridge between innate and adaptive immunity. NK cells = lymphocytes of innate; kill without antigen presentation. |
| Antibody structure | Y-shaped; 2 heavy + 2 light chains; disulphide bonds; variable domains (antigen-binding, unique) + constant domains (class-determining). Bivalent (monomer). 5 classes: IgG, IgA, IgM, IgE, IgD. |
| IgG | Most abundant (75% serum). Dominant in secondary response. Only Ig crossing placenta → foetal passive immunity. Also in breast milk. |
| IgM | Pentamer. Dominant in primary response. Best complement-fixer. ABO blood group antibodies. First BCR on naive B cells. |
| IgA | Secretory IgA in mucosal secretions. Most abundant Ig in colostrum/breast milk. Prevents antigen entry into blood. Mucosal immunity. |
| IgE | Allergic reactions (mast cells → histamine). Also against parasites. Lowest serum concentration. |
| Innate immunity | Non-specific, from birth, no memory. 4 barriers: Physical (skin, mucus), Physiological (saliva, acid, fever), Cellular (neutrophils, macrophages, NK cells), Cytokine (interferons — from virus-infected cells to protect uninfected cells). |
| Acquired immunity | Specific, has memory. Primary response (slow, low) → memory cells → Secondary response (fast, high). Humoral (B cells, antibodies) + Cell-mediated (T cells, CMI). |
| Active vs Passive | Active: body makes own antibodies (slow, long-lasting, has memory) — infection/vaccination. Passive: readymade antibodies given (fast, short-lived, no memory) — placental IgG, colostrum IgA, anti-serum. |
| Vaccination | Exploits immunological memory. Types: Live-attenuated (BCG, OPV, MMR), Killed (Covaxin), Subunit (Hep B, HPV), Toxoid (tetanus), mRNA (Pfizer — Nobel 2023), Viral vector (Covishield). India: UIP, Mission Indradhanush, Polio-free 2014. |
| Key CA | Nobel 2023: mRNA vaccines (Karikó & Weissman). Nobel 2018: immune checkpoint (cancer therapy). ZyCov-D (world's first DNA vaccine, India). iNCOVACC (world's first intranasal COVID vaccine, India). CERVAVAC (India's HPV vaccine). CAR-T cell therapy approved India 2024. HIV → destroys CD4+ TH cells → AIDS. |
Trap 1 — "B cells mature in the thymus; T cells mature in bone marrow" → REVERSED! WRONG! It is exactly the opposite: T cells mature in Thymus; B cells mature in Bone marrow. Both originate (precursors formed) in bone marrow. But T cell precursors migrate to the thymus for maturation. Memory trick: B = Bone, T = Thymus. This is one of the most commonly reversed facts in exams.
Trap 2 — "IgA crosses the placenta to give passive immunity to foetus" → WRONG! Only IgG crosses the placenta. IgA (secretory) is found in colostrum/breast milk and gives mucosal passive immunity to the newborn AFTER birth — not before (via placenta). The distinction: placenta = IgG; colostrum = IgA. IgM is too large to cross. IgE and IgD don't cross either.
Trap 3 — "Interferons are antibodies produced by plasma cells against viruses" → WRONG! Interferons are proteins (not antibodies) secreted by VIRUS-INFECTED CELLS — not by plasma cells. They are part of the INNATE immune system (non-specific, no memory). They warn and protect neighbouring uninfected cells. Antibodies are produced by plasma B cells and are specific to one antigen. Interferons act broadly against many viruses.
Trap 4 — "The primary immune response is stronger and faster than the secondary response" → WRONG! It is exactly opposite: Primary response is SLOW and WEAK (first exposure); Secondary response is FAST and STRONG (re-exposure). The secondary response is stronger because memory B and T cells are already present and recognise the antigen immediately. This is why you need multiple doses of some vaccines (primary course) and why booster doses dramatically amplify immunity.
Trap 5 — "Helper T cells directly kill virus-infected cells" → WRONG! Helper T cells (CD4+) do NOT directly kill infected cells. Their role is to COORDINATE/ACTIVATE other immune cells: they activate macrophages (for phagocytosis), activate Cytotoxic T cells (CD8+ — which actually kill infected cells), and activate B cells (for antibody production). It is the Cytotoxic T cells (CD8+) that directly kill virus-infected cells and cancer cells. HIV's devastating effect is precisely because it destroys Helper T cells — without them, the entire coordination of adaptive immunity collapses.


